(Q34715947)

4 August 2017

1 reference

title

Dexrazoxane for anthracycline extravasation (English)

1 reference

4 August 2017

Seppo W Langer

1

1 reference

4 August 2017

publication date

1 August 2007

1 reference

Expert Review of Anticancer Therapy

4 August 2017

published in

1 reference

4 August 2017

volume

7

1 reference

4 August 2017

issue

8

1 reference

4 August 2017

page(s)

1081-1088

1 reference

Management of anthracycline extravasation injuries

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.8.1081

Drug extravasation in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.8.1081

Skin ulcers due to adriamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.8.1081

The management of inadvertent subcutaneous adriamycin infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.8.1081

21 January 2018

Extravasation injuries.

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.8.1081

Cutaneous toxicities of cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.8.1081

Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.8.1081

The doxorubicin-cardioprotective drug dexrazoxane undergoes metabolism in the rat to its metal ion-chelating form ADR-925.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.8.1081

Metabolism of dexrazoxane (ICRF-187) used as a rescue agent in cancer patients treated with high-dose etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.8.1081

Dihydroorotase catalyzes the ring opening of the hydrolysis intermediates of the cardioprotective drug dexrazoxane (ICRF-187).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.8.1081

Metabolism of the one-ring open metabolites of the cardioprotective drug dexrazoxane to its active metal-chelating form in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.8.1081

A new conservative approach to extravasation of anthracyclines with dimethylsulfoxide and dexrazoxane

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.8.1081

Dexrazoxane-a promising antidote in the treatment of accidental extravasation of anthracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.8.1081

Dexrazoxane for anthracycline extravasation and GM-CSF for skin ulceration and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.8.1081

Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.8.1081

10.1586/14737140.7.8.1081

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference